Inderes has had so many negative revisions hit their buy recommendations that these should definitely be taken with a bit of humor. It’s part of the game. 
But as Atte already reminded, the negative revision was quite expected and in the forecasts. And Admicom has a “add” recommendation.
And investors should look ahead. A negative revision in October 2025 for that fiscal year may not be very dramatic, unless it significantly underperforms expectations.
Recommendations are easily short-term, as target prices are for 12 months ahead. But they shouldn’t be twisted because of an upcoming negative revision if it’s not expected to be dramatic for long-term cash flows.